These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6833327)

  • 1. Comparative evaluation of cefamandole and cephalothin in the treatment of experimental Staphylococcus aureus osteomyelitis in rabbits.
    Mader JT; Wilson KJ
    J Bone Joint Surg Am; 1983 Apr; 65(4):507-13. PubMed ID: 6833327
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of BL-S786 with cephalothin, cefamandole and cefoxitin in vitro and in treatment of experimental infections in mice.
    Goering RV; Sanders CC; Sanders W
    J Antibiot (Tokyo); 1978 Apr; 31(4):363-72. PubMed ID: 306989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cefoperazone treatment of experimental endocarditis.
    Snepar RA; Carrizosa J; Kobasa WD; Kaye D
    Antimicrob Agents Chemother; 1981 May; 19(5):773-6. PubMed ID: 6457556
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In-vitro activities of cefamandole and cephalothin against 1,881 clinical isolates. A multi-center study.
    Barry AL; Schoenknect FD; Shadomy S; Sherris JC; Thornsberry C; Washington JA; Kammer RB
    Am J Clin Pathol; 1979 Nov; 72(5):858-60. PubMed ID: 506998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the in vitro activity of cephalothin and cefamandole on methillicin-resistant strains of Staphylococcus aureus and epidermidis].
    Bianchi P; Caroppo BG; Pasticci MB; Galuppo L; Frongillo RF
    Clin Ter; 1984 Feb; 108(4):283-9. PubMed ID: 6232064
    [No Abstract]   [Full Text] [Related]  

  • 6. ["In vitro" activity of cefamandole, cefalotin, cefoxitin and cefuroxim against enterobacteria and Staphylococcus aureus isolated in hospital (author's transl)].
    Thabaut A; Durosoir JL; Saliou P
    Pathol Biol (Paris); 1979 Dec; 27(10):649-54. PubMed ID: 395496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of cefamandole against methicillin-resistant strains of Staphylococcus aureus in vitro and in experimental infections.
    Hirschl A; Stanek G; Rotter M
    J Antimicrob Chemother; 1984 May; 13(5):429-35. PubMed ID: 6735962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of second generation cephalosporins: cefamandole, cefoxitine, cefuroxime. Reccomendations by working group].
    Acta Clin Belg; 1980; 35(3):199-201. PubMed ID: 7456969
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination of an inoculum effect with various cephalosporins among clinical isolates of methicillin-susceptible Staphylococcus aureus.
    Nannini EC; Stryjewski ME; Singh KV; Rude TH; Corey GR; Fowler VG; Murray BE
    Antimicrob Agents Chemother; 2010 May; 54(5):2206-8. PubMed ID: 20211890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of cefamandole, cephalothin, ampicillin, and chloramphenicol in experimental Escherichia coli meningitis.
    Beam TR; Allen JC
    Antimicrob Agents Chemother; 1980 Jan; 17(1):37-42. PubMed ID: 6986115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on drug therapy. IV. Parenteral cephalosporins.
    Dahl SL; Elenbaas J; Hamburger S
    J Am Med Womens Assoc (1972); 1980 Apr; 35(4):99-100, 107-8. PubMed ID: 6246160
    [No Abstract]   [Full Text] [Related]  

  • 12. Importance of beta-lactamase inactivation in treatment of experimental endocarditis caused by Staphylococcus aureus.
    Goldman PL; Petersdorf RG
    J Infect Dis; 1980 Mar; 141(3):331-7. PubMed ID: 6965978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative in-vitro activity of cefamandole, cefoxitin, cefuroxime and cephalothin.
    Brorson JE; Norrby R
    Scand J Infect Dis Suppl; 1978; (13):88-93. PubMed ID: 278150
    [No Abstract]   [Full Text] [Related]  

  • 14. [Cefamandole: in vitro and in vivo activity].
    Martinetto P; Valtz A; Cavallo GP; Angeretti A
    G Batteriol Virol Immunol; 1979; 72(1-6):44-61. PubMed ID: 553842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Fundamental and clinical studies of cefamandole sodium in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1979 Sep; 32(9):912-29. PubMed ID: 387994
    [No Abstract]   [Full Text] [Related]  

  • 16. Susceptibility of Staphylococcus aureus to cefaclor and cephalothin: laboratory and clinical studies.
    Gray BM; Hubbell CA; Dillon HC
    Antimicrob Agents Chemother; 1978 Jun; 13(6):988-91. PubMed ID: 677865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative efficacy and tolerance of cefamandole and cephalothin as prophylaxis for open heart surgery: a randomized double-blind study.
    Parr GV; Aber RC
    J Cardiovasc Surg (Torino); 1982; 23(4):305-8. PubMed ID: 7107688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cefamandole for the therapy of serious Staphylococcus aureus infections.
    Eng RH; Corrado ML; Tillotson J; Gombert M; Cherubin C; Landesman S
    J Antimicrob Chemother; 1985 Nov; 16(5):663-6. PubMed ID: 4077774
    [No Abstract]   [Full Text] [Related]  

  • 19. Cross-resistance between methicillin and cephalosporins for staphylococci: a general assumption not true for cefamandole.
    Frongillo RF; Bianchi P; Moretti A; Pasticci MB; Ripa S; Pauluzzi S
    Antimicrob Agents Chemother; 1984 May; 25(5):666-8. PubMed ID: 6563877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with cefamandole for treatment of serious bone and joint infections.
    Levine LR; McCain E
    J Infect Dis; 1978 May; 137 Suppl():S119-S124. PubMed ID: 649996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.